Russia to sell 100 million doses of COVID-19 vaccine to India

iStock

Russia's sovereign wealth fund has agreed to supply 100 million doses of its coronavirus vaccine, Sputnik-V, to Indian drug company Dr Reddy's Laboratories, the fund said on Wednesday.

The deal comes after the Russian Direct Investment Fund (RDIF) reached agreements with Indian manufacturers to produce 300 million doses of the vaccine in India, which is a major consumer of Russian oil and arms.

Dr Reddy's, one of India's top pharmaceutical companies, will carry out Phase III clinical trials of the vaccine in India, pending regulatory approval, RDIF said in a statement.

Deliveries to India could begin in late 2020, it said, adding this was subject to the completion of trials and the vaccine's registration by regulatory authorities in India.

Russia was the first country to licence a novel coronavirus vaccine before large-scale Phase III trials were complete, stirring concern among scientists and doctors about the safety and efficacy of the shot.

The Phase I and II results had shown promise, G V Prasad, co-chairman of Dr Reddy's, was cited in the RDIF statement as saying.

"Sputnik V vaccine could provide a credible option in our fight against COVID-19 in India," he said.

There was no detail about the price of the vaccine but RDIF has said previously it was not aiming at making a profit, just covering costs.

The agreement comes as India's coronavirus cases surged past 5 million on Wednesday, piling pressure on hospitals grappling with unreliable supplies of oxygen that they need to treat tens of thousands of critical patients.

India is only the second country in the world to cross the grim milestone and said this week it is considering granting an emergency authorisation for a vaccine, particularly for the elderly and people in high-risk workplaces.

The RDIF has already reached vaccine supply deals with Kazakhstan, Brazil and Mexico. It has also signed a memorandum with the Saudi Chemical company.

Russia has billed Sputnik-V as the first vaccine against the coronavirus to be registered in the world. Phase III trials, involving at least 40,000 people, were launched in Russia on August 26 but have yet to be completed. 

More from International News

  • Turkey detains 11 over ski resort hotel fire

    Turkey has detained 11 people as part of an investigation into a fire that killed 79 people and injured dozens at a ski resort in the Bolu mountains, Justice Minister Yilmaz Tunc said on Wednesday.

  • Guterres: Climate crisis, uncontrolled AI possible existential threats

    The climate crisis and an unlimited expansion of artificial intelligence could be existential threats for humanity, United Nations Secretary-General Antonio Guterres said on Wednesday, adding AI should serve humanity and not the other way around.

  • Prince Harry hails 'monumental' legal win over Murdoch newspapers

    Prince Harry claimed a "monumental" victory over Rupert Murdoch's UK newspaper group on Wednesday after the publisher settled his lawsuit, admitting unlawful actions at its Sun tabloid for the first time and paying substantial damages.

  • Trump pardons 'Silk Road' founder Ulbricht

    US President Donald Trump has pardoned Silk Road founder Ross Ulbricht, who was sentenced to life in prison for running an underground online marketplace where drug dealers and others conducted more than $200 million in illicit trade using bitcoin.

Blogs